Medgenics Announces Public Offering of Common Stock

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Medgenics Announces Public Offering of Common Stock

PHILADELPHIA, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. As part of this proposed offering, Medgenics intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered to the public. Medgenics has developed a proprietary ex vivo gene therapy platform for the sustained production and delivery of therapeutic proteins and peptides using a patient's own tissue. The company focuses on rare and orphan diseases.

Piper Jaffray & Co. is acting as sole book-running manager for the proposed offering.

All of the shares to be sold in the proposed offering are being sold by Medgenics. Net proceeds will be used for the following purposes: (i) clinical development of TARGT EPO ™ for three renal anemia and two hematological indications, (ii) clinical development of TARGT GLP-2 ™ for short bowel syndrome, (iii) research and development activities with Children's Hospital of Philadelphia under the recently announced collaboration agreement, (iv) advancement of additional preclinical programs, and (v) general corporate purposes.

A shelf registration statement relating to the shares of common stock described above has been previously filed with and declared effective by the U.S. Securities and Exchange Commission (SEC). This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

This offering is being made by means of a prospectus supplement and related prospectus. A preliminary prospectus supplement relating to the offering will be filed with the SEC and will be available on its website at www.sec.gov . Copies of the preliminary prospectus supplement and accompanying prospectus may be obtained from Piper Jaffray & Co. by mail at 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, Attention: Prospectus Department, by telephone at (800) 747-3924 or by e-mail at prospectus@pjc.com .

About Medgenics, Inc.

Medgenics is developing TARGT ™ (Transduced Autologous Restorative Gene Therapy), a proprietary ex vivo gene therapy platform for the sustained production and delivery of therapeutic proteins and peptides using a patient's own tissue, for the treatment of rare and orphan diseases. For more information, visit the Company's website at www.medgenics.com .

Forward-looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995, which include all statements other than statements of historical fact, including (without limitation) those regarding the Company's financial position, its development and business strategy, its product candidates and the plans and objectives of management for future operations. The Company intends that such forward-looking statements be subject to the safe harbors created by such laws. Forward-looking statements are sometimes identified by their use of the terms and phrases such as "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning, "expect," "believe," "will," "will likely," "should," "could," "would," "may" or the negative of such terms and other comparable terminology. All such forward-looking statements are based on current expectations and are subject to risks and uncertainties. Should any of these risks or uncertainties materialize, or should any of the Company's assumptions prove incorrect, actual results may differ materially from those included within these forward-looking statements. Accordingly, no undue reliance should be placed on these forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, the events described in the forward-looking statements contained in this release may not occur.

Medgenics, Inc. John Leaman Brian Piper 240-899-5554 Stern Investor Relations Beth DelGiacco 212-362-1200

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cytonics Refines CYT-108 Trial Plan With Decade OA Data

Updated Category News Views 89

A Better Map Is Not a Working Drug Knee osteoarthritis has chewed up plenty of promising development plans because the disease moves at an aggravatingly uneven crawl. Cytonics has done something sensible before pushing deeper into CYT-108: it went back to long-term untreated patient data and asked which knees actually deteriorate fast enough for a trial to detect...

Continue Reading
Markel Elevates War Risk Expertise in London Market

Updated Category News Views 165

A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 134

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
TGHL Eyes U.S. Battery Shift Through EnChem Merger

Updated Category News Views 249

A Policy Squeeze Is Rewriting the Battery Map Battery supply chains are getting shoved through a narrower gate, and that is exactly why this proposed deal deserves a hard look. The GrowHub Limited wants to acquire EnChem America, a Georgia-based lithium-ion battery electrolyte producer, and the timing is plainly built around Washington's push to reduce reliance on...

Continue Reading
Sinopec’s Algerian Outreach Reveals a Patient Long Game

Updated Category News Views 109

Soft Power Does Not Run a Refinery, but It Matters A short video contest in Algiers will not move an oilfield schedule or settle a hydrocarbons negotiation. That is precisely why this Sinopec-backed event deserves a sober look rather than a chest-thumping one. On Nov. 15, Sinopec Group and the Chinese Embassy in Algeria co-hosted the final of their second youth cultural...

Continue Reading
Cold-Season Cleaning Advice Has a Practical Catch!

Updated Category News Views 53

Remote Controls Are Nobody’s First Suspect A television remote can make the rounds all evening and never see a cloth, which is precisely why Maid Brigade’s cold-and-flu-season reminder lands as common sense rather than revelation. The Scottsdale cleaning company is telling households to look past the usual kitchen counter and bathroom sink routine. Fair enough. People...

Continue Reading
BLLN Faces Fresh Questions After Short-Seller Report

Updated Category News Views 91

A six-percent air pocket is one thing; a disclosure mismatch is another beast entirely. BillionToOne shares fell on November 18 after short-seller Fuzzy Panda Research alleged the company had not disclosed meaningful regulatory scrutiny, including an alleged Tennessee matter in which regulators suspected fraud in 2024. That is an allegation from a short seller, not a...

Continue Reading
Veterans United Foundation Marks 15 Years of Giving

Updated Category News Views 62

A Milestone Measured in More Than Checks Fifteen years can turn a workplace charity into background noise, but this one plainly has not drifted into autopilot. Veterans United Foundation closed its 2026 anniversary campaign, called The Good Goes On, with $1.5 million directed to charitable organizations, 1,145 employee volunteers, and 2,680 hours of hands-on work. That is...

Continue Reading
APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 50

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
HiTHIUM's 8-Hour Storage Pitch Faces Real Grid Tests

Updated Category News Views 89

Eight hours of stored electricity is where the sales brochure meets the ugly parts of the grid. HiTHIUM arrived at RE+ 2026 in Las Vegas, held November 17 through 19, with a broad storage pitch: systems ranging from two to eight hours, lithium-ion and sodium-ion chemistry, plus the software and validation work needed to make a battery plant behave when the local grid gets...

Continue Reading

Top 5 Most Recently Viewed Articles

Wind River Launches Innovative eLxr Pro for Modern Deployments

Updated Category News Views 314

Transforming Edge Computing with eLxr Pro Wind River, a leader in intelligent edge software solutions, has just launched a groundbreaking product, eLxr Pro. This is a commercial enterprise Linux distribution tailored to meet the rising demands of cloud-to-edge deployments, significantly improving performance and operational capabilities across a range of sectors. Meeting...

Continue Reading
VirnetX Welcomes Dr. Jamison as New Chief Technical Officer

Updated Category News Views 541

VirnetX Appoints a New Chief Technical Officer VirnetX Holding Corporation (NYSE: VHC) is excited to announce the appointment of Dr. John Anthony Jamison as their new Chief Technical Officer (CTO). His extensive background significantly bolsters the team’s expertise in secure communications technology. Dr. Jamison's Impressive Background Dr. Jamison brings a wealth of...

Continue Reading
NDEX Systems Enhances Advisor Workflows with New Technology

Updated Category News Views 188

Innovative Integration by NDEX Systems MONTREAL — NDEX Systems, a leader in multi-custodian data utility and wealth-management solutions, has recently unveiled a new integration that significantly enhances the advisor experience. This development introduces a sophisticated single sign-on (SSO) connection and a fully integrated client onboarding process with the Schwab...

Continue Reading
Transforming Agriculture: The Rise of Regenerative Practices

Updated Category News Views 239

The Rise of Regenerative Agriculture In the current agricultural landscape, regenerative agriculture has emerged as a crucial response to the pressing issues of climate change, soil degradation, and food security. This innovative farming method doesn't just optimize food production; it revitalizes ecosystems and offers economic advantages for farmers around the globe....

Continue Reading
Ericsson's Q2 2025 Performance Highlights and Future Strategies

Updated Category News Views 367

Financial Overview of Q2 2025 Ericsson has reported significant advancements in its financial performance for the second quarter of 2025. With operational excellence, the company has seen a remarkable 48% adjusted gross margin, marking a three-year high in adjusted EBITA margin. This reflects a strong commitment to strategic execution and operational improvements....

Continue Reading